Related Experiment Video
Updated: Sep 13, 2025

15:12
Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
Published on: May 10, 2014
14.6K
Special Issue "Research Advances on Cystic Fibrosis and CFTR Protein"
1Istituto di Biofisica, Consiglio Nazionale delle Ricerche (CNR), Via De Marini, 6, 16149 Genova, Italy.
International Journal of Molecular Sciences
|July 29, 2025
Summary
Cystic fibrosis (CF) is a common genetic disorder affecting Caucasian populations. Early diagnosis and management are crucial for improving patient outcomes and quality of life.
Area of Science:
- Genetics and genomics
- Pediatric medicine
- Respiratory diseases
Background:
- Cystic fibrosis (CF) is a prevalent autosomal recessive disorder in Caucasian populations.
- Affecting approximately 1 in 2500-3500 live births in Europe, CF presents a significant public health challenge.
- The disorder necessitates comprehensive understanding for effective management.
Discussion:
- The genetic basis of CF involves mutations in the CFTR gene.
- Understanding CFTR function is key to developing targeted therapies.
- Research focuses on genotype-phenotype correlations to personalize treatment.
Key Insights:
- CF impacts multiple organ systems, primarily the lungs and digestive tract.
- Early detection through newborn screening improves long-term prognosis.
- Multidisciplinary care is essential for managing CF complications.
Outlook:
- Advancements in gene therapy and modulator drugs offer new hope for CF patients.
- Continued research aims to address unmet needs and achieve a cure.
- Focus on improving quality of life and extending lifespan for individuals with CF.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
366
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
366
Cystic Fibrosis: Management
224
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
224

